본문 바로가기
KERD
논문KCI 등재

Aortic aneurysms: current pathogenesis and therapeutic targets

이미란|Cho Min Ji|Park Jong-Gil
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2023.12|Experimental and Molecular Medicine|제55권 |pp. 2519-2530|DOI 10.1038/s12276-023-01130-w

2

조회

0

다운로드

1

인용

0

참고문헌

주제분류생화학

초록

Aortic aneurysm is a chronic disease characterized by localized expansion of the aorta, including the ascending aorta, arch, descending aorta, and abdominal aorta. Although aortic aneurysms are generally asymptomatic, they can threaten human health by sudden death due to aortic rupture. Aortic aneurysms are estimated to lead to 150,000 ~ 200,000 deaths per year worldwide. Currently, there are no effective drugs to prevent the growth or rupture of aortic aneurysms; surgical repair or endovascular repair is the only option for treating this condition. The pathogenic mechanisms and therapeutic targets for aortic aneurysms have been examined over the past decade; however, there are unknown pathogenic mechanisms involved in cellular heterogeneity and plasticity, the complexity of the transforming growth factor-β signaling pathway, inflammation, cell death, intramural neovascularization, and intercellular communication. This review summarizes the latest research findings and current pathogenic mechanisms of aortic aneurysms, which may enhance our understanding of aortic aneurysms.

Abstract

Aortic aneurysm is a chronic disease characterized by localized expansion of the aorta, including the ascending aorta, arch, descending aorta, and abdominal aorta. Although aortic aneurysms are generally asymptomatic, they can threaten human health by sudden death due to aortic rupture. Aortic aneurysms are estimated to lead to 150,000 ~ 200,000 deaths per year worldwide. Currently, there are no effective drugs to prevent the growth or rupture of aortic aneurysms; surgical repair or endovascular repair is the only option for treating this condition. The pathogenic mechanisms and therapeutic targets for aortic aneurysms have been examined over the past decade; however, there are unknown pathogenic mechanisms involved in cellular heterogeneity and plasticity, the complexity of the transforming growth factor-β signaling pathway, inflammation, cell death, intramural neovascularization, and intercellular communication. This review summarizes the latest research findings and current pathogenic mechanisms of aortic aneurysms, which may enhance our understanding of aortic aneurysms.

참고문헌 (131)

  1. Golledge, J., "Abdominal aortic aneurysm : update on pathogenesis and medical treatments", Nat. Rev. Cardiol, 16, pp.225~242 (2019)
  2. Liu, B., "Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm", Am. J. Physiol. Heart Circ. Physiol, 318, pp.H652~H670 (2020)
  3. Qian, G., "Abdominal aortic aneurysm formation with a focus on vascular smooth muscle cells", Life, 12, pp.191~ (2022)
  4. Gao, J., "The mechanism and therapy of aortic aneurysms", Signal Transduct. Target. Ther, 8, pp.55~ (2023)
  5. Shen, Y. H., "Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections", Curr. Probl. Surg, 54, pp.95~155 (2017)
  6. Pinard, A., "Genetics of thoracic and abdominal aortic diseases", Circ. Res, 124, pp.588~606 (2019)
  7. Kuivaniemi, H., "Understanding the pathogenesis of abdominal aortic aneurysms", Expert Rev. Cardiovasc. Ther, 13, pp.975~987 (2015)
  8. Li, Y., "Molecular and cellular dynamics of aortic aneurysms revealed by single-cell transcriptomics", Arterioscler. Thromb. Vasc. Biol, 41, pp.2671~2680 (2021)
  9. Jauhiainen, S., "Large vessel cell heterogeneity and plasticity : focus in aortic aneurysms", Arterioscler. Thromb. Vasc. Biol, 42, pp.811~818 (2022)
  10. Li, Y., "Single-cell transcriptome analysis reveals dynamic cell populations and differential gene expression patterns in control and aneurysmal human aortic tissue", Circulation, 142, pp.1374~1388 (2020)
  11. Zhao, G., "Single-cell RNA sequencing reveals the cellular heterogeneity of aneurysmal infrarenal abdominal aorta", Cardiovasc. Res, 117, pp.1402~1416 (2021)
  12. Branchetti, E., "Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm", Cardiovasc. Res, 100, pp.316~324 (2013)
  13. Fei, J., "Novel mechanism controlling phenotypic modulation of vascular smooth muscle cells", Circ. Res, 119, pp.463~469 (2016)
  14. Liu, R., "Ten-eleven translocation-2(TET2)is a master regulator of smooth muscle cell plasticity", Circulation, 128, pp.2047~2057 (2013)
  15. Dobnikar, L., "Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels", Nat. Commun, 9, pp.4567~ (2018)
  16. Luo, W., "Critical role of cytosolic DNA and its sensing adaptor STING in aortic degeneration, dissection, and rupture", Circulation, 141, pp.42~66 (2020)
  17. Yuan, Z., "Abdominal aortic aneurysm : roles of inflammatory cells", Front. Immunol, 11, pp.609161~ (2020)
  18. Davis, F. M., "Inhibition of macrophage histone demethylase JMJD3 protects against abdominal aortic aneurysms", J. Exp. Med, 218, pp.e20201839~ (2021)
  19. Yang, H., "Single-cell RNA sequencing reveals heterogeneity of vascular cells in early stage murine abdominal aortic aneurysm-brief report", Arterioscler. Thromb. Vasc. Biol, 41, pp.1158~1166 (2021)
  20. Mould, K. J., "Single cell RNA sequencing identifies unique inflammatory airspace macrophage subsets", JCI Insight, 4, pp.e126556~ (2019)
  21. Nahrendorf, M., "Abandoning M1", M2 for a network model of macrophage function, 2016, pp.119, 414~417
  22. Quintana, R. A., "Cellular mechanisms of aortic aneurysm formation", Circ. Res, 124, pp.607~618 (2019)
  23. Lu, H., "Vascular smooth muscle cells in aortic aneurysm : from genetics to mechanisms", J. Am. Heart Assoc, 10, pp.e023601~ (2021)
  24. Petsophonsakul, P., "Role of vascular smooth muscle cell phenotypic switching and calcification in aortic aneurysm formation", Arterioscler. Thromb. Vasc. Biol, 39, pp.1351~1368 (2019)
  25. Hadi, T., "Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells", Nat. Commun, 9, pp.5022~ (2018)
  26. McCormick, M. L., "Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms", Arterioscler. Thromb. Vasc. Biol, 27, pp.461~469 (2007)
  27. Pyeritz, R. E., "The Marfan syndrome: diagnosis and management", N. Engl. J. Med, 300, pp.772~777 (1979)
  28. Dietz, H. C., "Clustering of fibrillin(FBN1)missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains", Hum. Mutat, 1, pp.366~374 (1992)
  29. Whiteman, P., "Fibrillin-1 misfolding and disease", Antioxid. Redox Signal, 8, pp.338~346 (2006)
  30. Lee, V. S., "Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans", Proc. Natl Acad. Sci. USA, 113, pp.8759~8764 (2016)
  31. Gdynia, H. J., "Connective tissue disorders in dissections of the carotid or vertebral arteries", J. Clin. Neurosci, 15, pp.489~494 (2008)
  32. Csiszar, K., "Lysyl oxidases : a novel multifunctional amine oxidase family", Prog. Nucleic Acid Res. Mol. Biol, 70, pp.1~32 (2001)
  33. Guo, D. C., "LOX mutations predispose to thoracic aortic aneurysms and dissections", Circ. Res, 118, pp.928~934 (2016)
  34. Guo, D. C., "Mutations in smooth muscle alpha-actin(ACTA2)cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease", Am. J. Hum. Genet, 84, pp.617~627 (2009)
  35. Zhu, L., "Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm", aortic dissection and patent ductus arteriosus, 2006, pp.38, 343~349
  36. Shalata, A., "Fatal thoracic aortic aneurysm and dissection in a large family with a novel MYLK gene mutation : delineation of the clinical phenotype", Orphanet. J. Rare Dis, 13, pp.41~ (2018)
  37. Wallace, S. E., "MYLK pathogenic variants aortic disease presentation, pregnancy risk, and characterization of pathogenic missense variants", Genet. Med, 21, pp.144~151 (2019)
  38. Guo, D. C., "Mutations in smooth muscle alpha-actin(ACTA2)lead to thoracic aortic aneurysms and dissections", Nat. Genet, 39, pp.1488~1493 (2007)
  39. Pannu, H., "MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II", Hum. Mol. Genet, 16, pp.2453~2462 (2007)
  40. Pyun Jung-Hoon, "Inducible Prmt1 ablation in adult vascular smooth muscle leads to contractile dysfunction and aortic dissection", Experimental and Molecular Medicine, 53, pp.1~11 (2021), 생화학분자생물학회[DOI]
  41. Tzavlaki, K., "TGF-beta signaling", Biomolecules, 10, pp.487~ (2020)
  42. Derynck, R., "Specificity, versatility, and control of TGF-beta family signaling", Sci. Signal, 12, pp.eaav5183~ (2019)
  43. ten Dijke, P., "Extracellular control of TGFbeta signalling in vascular development and disease", Nat. Rev. Mol. Cell Biol, 8, pp.857~869 (2007)
  44. Robertson, I. B., "Regulation of the bioavailability of TGF-beta and TGF-beta-related proteins", Cold Spring Harb. Perspect. Biol, 8, pp.a021907~ (2016)
  45. Ge, G., "BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein", J. Cell Biol, 175, pp.111~120 (2006)
  46. Li, W., "Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis", J. Clin. Invest, 124, pp.755~767 (2014)
  47. Chen, P. Y., "Smooth muscle cell reprogramming in aortic aneurysms", Cell Stem Cell, 26, pp.542~557 (2020)
  48. Mizuguchi, T., "Heterozygous TGFBR2 mutations in Marfan syndrome", Nat. Genet, 36, pp.855~860 (2004)
  49. Tran-Fadulu, V., "Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2", Mutat. J. Med. Genet, 46, pp.607~613 (2009)
  50. Lindsay, M. E., "Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm", Nat. Genet, 44, pp.922~927 (2012)
  51. Boileau, C., "TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome", Nat. Genet, 44, pp.916~921 (2012)
  52. Schepers, D., "A mutation update on the LDS-associated genes TGFB2", 3 and SMAD2, Hum. Mutat, pp.2018, 39[DOI]
  53. Loeys, B. L., "Aneurysm syndromes caused by mutations in the TGF-beta receptor", N. Engl. J. Med, 355, pp.788~798 (2006)
  54. Bertoli-Avella, A. M., "Mutations in a TGF-beta ligand, TGFB3, cause syndromic aortic aneurysms and dissections", J. Am. Coll. Cardiol, 65, pp.1324~1336 (2015)
  55. van de Laar, I. M., "Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis", Nat. Genet, 43, pp.121~126 (2011)
  56. Gallo, E. M., "Angiotensin II-dependent TGF-beta signaling contributes to Loeys-Dietz syndrome vascular pathogenesis", J. Clin. Invest, 124, pp.448~460 (2014)
  57. Hara, H., "Activation of TGF-beta signaling in an aortic aneurysm in a patient with Loeys-Dietz syndrome caused by a novel loss-of-function variant of TGFBR1", Hum. Genome Var, 6, pp.6~ (2019)
  58. Habashi, J. P., "Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome", Science, 312, pp.117~121 (2006)
  59. Neptune, E. R., "Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome", Nat. Genet, 33, pp.407~411 (2003)
  60. Ruddy, J. M., "Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta", Circulation, 120, pp.S262~S268 (2009)
  61. Doyle, A. J., "Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm", Nat. Genet, 44, pp.1249~1254 (2012)
  62. Wang, Y., "TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice", J. Clin. Invest, 120, pp.422~432 (2010)
  63. Angelov, S. N., "TGF-beta(Transforming Growth Factor-beta)signaling protects the thoracic and abdominal aorta from angiotensin II-induced pathology by distinct mechanisms", Arterioscler. Thromb. Vasc. Biol, 37, pp.2102~2113 (2017)
  64. Chen, X., "TGF-beta neutralization enhances angII-induced aortic rupture and aneurysm in both thoracic and abdominal regions", PLoS One, 11, pp.e0153811~ (2016)
  65. King, V. L., "Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture", Circulation, 119, pp.426~435 (2009)
  66. Li, H., "Modulation of immune-inflammatory responses in abdominal aortic aneurysm : emerging molecular targets", J. Immunol. Res, 2018, pp.7213760~ (2018)
  67. Michineau, S., "Chemokine(C-X-C motif)receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects", Arterioscler. Thromb. Vasc. Biol, 34, pp.1747~1755 (2014)
  68. Gallo, A., "Circulating interferon-gamma-inducible Cys-X-Cys chemokine receptor 3 ligands are elevated in humans with aortic aneurysms and Cys-X-Cys chemokine receptor 3 is necessary for aneurysm formation in mice", J. Thorac. Cardiovasc. Surg, 143, pp.704~710 (2012)
  69. Anzai, A., "Adventitial CXCL1", G-CSF expression in response to acute aortic dissection triggers local neutrophil recruitment and activation leading to aortic rupture, 2015, pp.116, 612~623
  70. Moran, C. S., "Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes", Arterioscler. Thromb. Vasc. Biol, 33, pp.814~821 (2013)
  71. Zhang, J., "Chemokine(C-C motif)receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice", Cardiovasc. Res, 96, pp.543~551 (2012)
  72. Ishida, Y., "Prevention of CaCl(2)-induced aortic inflammation and subsequent aneurysm formation by the CCL3-CCR5 axis", Nat. Commun, 11, pp.5994~ (2020)
  73. Puchenkova, O. A., "Cytokines in abdominal aortic aneurysm : master regulators with clinical application", Biomark. Insights, 17, pp.11772719221095676~ (2022)
  74. Li, Y., "Discovery of crucial cytokines associated with abdominal aortic aneurysm formation by protein array analysis", Exp. Biol. Med, 244, pp.1648~1657 (2019)
  75. Lindeman, J. H., "Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta : IL-6-and IL-8-dominated inflammatory responses prevail in the human aneurysm", Clin. Sci, 114, pp.687~697 (2008)
  76. Middleton, R. K., "The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall : a protein array study", J. Vasc. Surg, 45, pp.574~580 (2007)
  77. Rohde, L. E., "Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation", Arterioscler. Thromb. Vasc. Biol, 19, pp.1695~1699 (1999)
  78. Yuwen, L., "A pilot study of protein microarray for simultaneous analysis of 274 cytokines between abdominal aortic aneurysm and normal aorta", Angiology, 70, pp.830~837 (2019)
  79. Harrison, S. C., "Interleukin-6 receptor pathways in abdominal aortic aneurysm", Eur. Heart J, 34, pp.3707~3716 (2013)
  80. Nishihara, M., "The role of IL-6 in pathogenesis of abdominal aortic aneurysm in mice", PLoS One, 12, pp.e0185923~ (2017)
  81. Paige, E., "Interleukin-6 receptor signaling and abdominal aortic aneurysm growth rates", Circ. Genom. Precis. Med, 12, pp.e002413~ (2019)
  82. Garbers, C., "Interleukin-6 : designing specific therapeutics for a complex cytokine", Nat. Rev. Drug Discov, 17, pp.395~412 (2018)
  83. Newman, K. M., "Cytokines that activate proteolysis are increased in abdominal aortic aneurysms", Circulation, 90, pp.II224~II227 (1994)
  84. Wu, X., "Sex-and disease-specific inflammasome signatures in circulating blood leukocytes of patients with abdominal aortic aneurysm", Mol. Med, 22, pp.505~518 (2016)
  85. Xiong, W., "Blocking TNF-alpha attenuates aneurysm formation in a murine model", J. Immunol, 183, pp.2741~2746 (2009)
  86. Isoda, K., "Inhibition of interleukin-1 suppresses angiotensin II-induced aortic inflammation and aneurysm formation", Int. J. Cardiol, 270, pp.221~227 (2018)
  87. Hingorani, A., "The effect of tumor necrosis factor binding protein and interleukin-1 receptor antagonist on the development of abdominal aortic aneurysms in a rat model", J. Vasc. Surg, 28, pp.522~526 (1998)
  88. Batra, R., "IL-1beta(Interleukin-1beta)and TNF-alpha(Tumor Necrosis Factor-alpha)impact abdominal aortic aneurysm formation by differential effects on macrophage polarization", Arterioscler. Thromb. Vasc. Biol, 38, pp.457~463 (2018)
  89. Pryshchep, O., "Vessel-specific Toll-like receptor profiles in human medium and large arteries", Circulation, 118, pp.1276~1284 (2008)
  90. Yan, H., "Antagonism of toll-like receptor 2 attenuates the formation and progression of abdominal aortic aneurysm", Acta Pharm. Sin. B, 5, pp.176~187 (2015)
  91. Decout, A., "The cGAS-STING pathway as a therapeutic target in inflammatory diseases", Nat. Rev. Immunol, 21, pp.548~569 (2021)
  92. Xiong, W., "Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model", J. Immunol, 172, pp.2607~2612 (2004)
  93. Chakraborty, A., "Programmed cell death in aortic aneurysm and dissection : a potential therapeutic target", J. Mol. Cell Cardiol, 163, pp.67~80 (2022)
  94. Henderson, E. L., "Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms", Circulation, 99, pp.96~104 (1999)
  95. Wang, Y. X., "Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis", Circulation, 111, pp.2219~2226 (2005)
  96. Jia, L. X., "Mechanical stretch-induced endoplasmic reticulum stress, apoptosis and inflammation contribute to thoracic aortic aneurysm and dissection", J. Pathol, 236, pp.373~383 (2015)
  97. Xiong, W., "Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model", Atherosclerosis, 202, pp.128~134 (2009)
  98. Jeong Se-Jin, "Deficiency of peroxiredoxin 2 exacerbates angiotensin II-induced abdominal aortic aneurysm", Experimental and Molecular Medicine, 52, pp.1~15 (2020), 생화학분자생물학회[DOI]
  99. Gao Ran, "Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosis", Experimental and Molecular Medicine, 54, pp.1~13 (2022), 생화학분자생물학회[DOI]
  100. Wang, Q., "Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation", Circ. Res, 116, pp.600~611 (2015)
  101. Ren, P., "Targeting the NLRP3 inflammasome with inhibitor MCC950 prevents aortic aneurysms and dissections in mice", J. Am. Heart Assoc, 9, pp.e014044~ (2020)
  102. Ren, J., "Key ferroptosis-related genes in abdominal aortic aneurysm formation and rupture as determined by combining bioinformatics techniques", Front. Cardiovasc. Med, 9, pp.875434~ (2022)
  103. Chen Liang, "Mesenchymal stem cell-derived extracellular vesicles protect against abdominal aortic aneurysm formation by inhibiting NET-induced ferroptosis", Experimental and Molecular Medicine, 55, pp.939~951 (2023), 생화학분자생물학회[DOI]
  104. Choke, E., "Increased angiogenesis at the site of abdominal aortic aneurysm rupture", Ann. N. Y. Acad. Sci, 1085, pp.315~319 (2006)
  105. Choke, E., "Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines", Arterioscler. Thromb. Vasc. Biol, 26, pp.2077~2082 (2006)
  106. Cockerill, G. W., "Angiogenesis : models and modulators", Int. Rev. Cytol, 159, pp.113~160 (1995)
  107. Nagy, J. A., "VEGF-A and the induction of pathological angiogenesis", Annu. Rev. Pathol, 2, pp.251~275 (2007)
  108. Choke, E., "Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice", J. Vasc. Surg, 52, pp.159~166 (2010)
  109. Xu, B., "Inhibition of VEGF(Vascular Endothelial Growth Factor)-A or its receptor activity suppresses experimental aneurysm progression in the aortic elastase infusion model", Arterioscler. Thromb. Vasc. Biol, 39, pp.1652~1666 (2019)
  110. Kessler, K., "Angiogenesis and remodelling in human thoracic aortic aneurysms", Cardiovasc. Res, 104, pp.147~159 (2014)
  111. Lu, S., "Applications of extracellular vesicles in abdominal aortic aneurysm", Front. Cardiovasc. Med, 9, pp.927542~ (2022)
  112. Wang, Y., "Involvement of macrophage-derived exosomes in abdominal aortic aneurysms development", Atherosclerosis, 289, pp.64~72 (2019)
  113. Dang, G., "T lymphocyte-derived extracellular vesicles aggravate abdominal aortic aneurysm by promoting macrophage lipid peroxidation and migration via pyruvate kinase muscle isozyme 2", Redox Biol, 50, pp.102257~ (2022)
  114. Martinez-Pinna, R., "Label-free quantitative proteomic analysis of human plasma-derived microvesicles to find protein signatures of abdominal aortic aneurysms", Proteom. Clin. Appl, 8, pp.620~625 (2014)
  115. Fernandez-Garcia, C. E., "Association of ficolin-3 with abdominal aortic aneurysm presence and progression", J. Thromb. Haemost, 15, pp.575~585 (2017)
  116. Hildebrandt, A., "Detection of atherosclerosis by small RNA-sequencing analysis of extracellular vesicle enriched serum samples", Front. Cell Dev. Biol, 9, pp.729061~ (2021)
  117. Spinosa, M., "Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147", FASEB J, 32, pp.fj201701138RR~ (2018)
  118. Hu, J., "Exosomal miR-17-5p from adipose-derived mesenchymal stem cells inhibits abdominal aortic aneurysm by suppressing TXNIP-NLRP3 inflammasome", Stem Cell Res. Ther, 13, pp.349~ (2022)
  119. Senemaud, J., "Translational relevance and recent advances of animal models of abdominal aortic aneurysm", Arterioscler. Thromb. Vasc. Biol, 37, pp.401~410 (2017)
  120. Erbel, R., "2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC)", Eur. Heart J, 35, pp.2873~2926 (2014)
  121. Golledge, J., "Mouse models for abdominal aortic aneurysm", Br. J. Pharmacol, 179, pp.792~810 (2022)
  122. Daugherty, A., "Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient", Mice. J. Clin. Invest, 105, pp.1605~1612 (2000)
  123. Daugherty, A., "Mouse models of abdominal aortic aneurysms", Arterioscler. Thromb. Vasc. Biol, 24, pp.429~434 (2004)
  124. Daugherty, A., "Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor-", -mice, 1999, pp.892, 108~118
  125. Daugherty, A., "Role of the renin-angiotensin system in the development of abdominal aortic aneurysms in animals and humans", Ann. N. Y. Acad. Sci, 1085, pp.82~91 (2006)
  126. Gertz, S. D., "Aneurysm of the rabbit common carotid artery induced by periarterial application of calcium chloride in vivo", J. Clin. Invest, 81, pp.649~656 (1988)
  127. Freestone, T., "Influence of hypercholesterolemia and adventitial inflammation on the development of aortic aneurysm in rabbits", Arterioscler. Thromb. Vasc. Biol, 17, pp.10~17 (1997)
  128. Chiou, A. C., "Murine aortic aneurysm produced by periarterial application of calcium chloride", J. Surg. Res, 99, pp.371~376 (2001)
  129. Longo, G. M., "Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms", J. Clin. Invest, 110, pp.625~632 (2002)
  130. Anidjar, S., "Elastase-induced experimental aneurysms in rats", Circulation, 82, pp.973~981 (1990)
  131. Bhamidipati, C. M., "Development of a novel murine model of aortic aneurysms using peri-adventitial elastase", Surgery, 152, pp.238~246 (2012)

관련 논문AI추천

Role of vascular smooth muscle cell in the inflammation of atherosclerosis박성하, 임소연생화학분자생물학회 · BMB Reports2014 · 제47권 제1호Increase of Vδ2+ T Cells That Robustly Produce IL-17A in Advanced Abdominal Aortic Aneurysm Tissues고영국, 김정환, 노태욱, 박수형, 서인호, 신의철, 이승준, 주현철대한면역학회 · Immune Network2021 · 제21권 제2호Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosisFan Tianfei, Fan Tianhui, Feng Xiaohang, Gao Ran, Ge Weipeng, Guo Wenjun, Hou Yangfeng, Jing He, Jin Mu, Li Bolun, Lu Jiakai, Pang Junling, Wang Jing, Yan Chen, Zhang Tiantian생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권 Mesenchymal stem cell-derived extracellular vesicles protect against abdominal aortic aneurysm formation by inhibiting NET-induced ferroptosisChen Liang, Liu Yuting, Li Yinan, Wang Guiming, Wang Zheyu, Xue Guanhua, Xu Yi, Yang Shuofei, Zhang Lan, Zhang Leiyang생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 발살바동을 침범한 상행대동맥류로 인해 발생한 급성심근경색증 사망: 부검 증례이호, 노상재, 장유라대한법의학회 · 대한법의학회지2023 · 제47권 제4호Cellular Senescence in Arterial DiseasesIppei Shimizu, Tohru Minamino한국지질동맥경화학회 · 지질·동맥경화학회지2020 · 제9권 제1호

이 간행물의 다른 논문 (225건)

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics김성영, Han Yeaeunpp. 1-12Grave-to-cradle: human embryonic lineage tracing from the postmortem bodyKu Eu Jeong, Choi Seock Hwan, Choi Yujin Angelina, Oh Ji Wonpp. 13-21Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesisKim Tae-Hee, Loe Adrian Kwan Ho, Zhu Lexinpp. 22-31TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cellsCha Hyuk-Jin, Kim Yun-Jeong, Go Young-Hyun, 정호창, Kwon Eun-Ji, Kim Seong-Min, Cheong Hyun Sub, Kim Wantae, Shin Hyoung Doo, Lee Haeseungpp. 32-42ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Nam Hae Yun, 김성학, 김승후, 최경철, Park Seung-Ho, Song Ji-Hye, Jeong Ji-Hoon, Kim Hyunhee, Jeong Minseok, Kong Min-Jeong, Son Jihyun, Jeong Ji-Eunpp. 43-54
원문 보기